Prescription drug · ANDA
Amoxapine NDC 62135-700
Amoxapine 25 mg/1 · Tablet · Oral · Chartwell RX, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62135-700-90 | 62135070090 | 90 TABLET in 1 BOTTLE (62135-700-90)Marketed from Sep 6, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amoxapine
- Generic name (nonproprietary)
- amoxapine
- Active ingredients
- Amoxapine — 25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Chartwell RX, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 072879
- Marketing start
- Listing expires
- Identifiers
- Product ID 62135-700_298fbb0d-737b-b42f-e063-6394a90ac69bSPL ID 298fbb0d-737b-b42f-e063-6394a90ac69bSPL set ID eed5e856-dd7b-4eaa-9dad-508f2bef9328RxCUI 197363, 197364, 197365, 197366UNII R63VQ857OTUPC 0362135702908, 0362135701901, 0362135700904, 0362135703301
- Pharmacologic class
- Tricyclic Antidepressant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462135070090followed by a unit qualifier and the quantityPackage 62135-0700-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Amoxapine is indicated for the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions. It is indicated for depression accompanied by anxiety or agitation.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 072879
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.